VETS, Veterans Exploring Treatment Solutions
VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 that funds U.S. veterans' access to psychedelic-assisted therapies through grants, research partnerships with Stanford and Ohio State, and veteran-focused policy advocacy.
- Company typePrivate
- Founded2019
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What VETS, Veterans Exploring Treatment Solutions does
VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 and headquartered in Coronado, California, that facilitates U.S. veteran access to psychedelic-assisted therapies for PTSD, traumatic brain injury, and other service-related conditions. Its core product is the Foundational Healing Grant program, which directly funds veterans to receive treatment at approved international and domestic clinics — by 2025, the program had supported 1,300+ veterans and spouses with 1,200+ grants awarded across 16 states, accompanied by longitudinal wellbeing assessments (350+ data points) used to build an outcomes evidence base.
The organization operates through three program pillars: Resources (grants, an E-Course, and a Foundational Healing Workbook), Research (clinical study partnerships with Stanford — including a Nature Medicine publication on MDMA-assisted therapy — and Ohio State), and Advocacy (federal and state policy work). Strategic research partnerships with major academic medical centers, alongside direct policy engagement, have helped VETS contribute to securing over $124M in public research funding, including a Texas $100M Ibogaine Initiative, California AB 1103, and a White House executive order on ibogaine research. The VALOR Coalition, launched in 2025 with major Veterans Service Organizations, extends this convening role.
VETS is funded through philanthropic donations rather than commercial revenue. In 2025, total fundraising was approximately $6.7M, drawn from individual donors (~$3.3M), foundations (~$1.99M), events (~$737K), and corporate giving (~$681K). The organization holds a 4-star Charity Navigator rating, has received Emmy nominations for the Netflix documentary "In Waves and War" (premiered November 2025), and reports a 100% veteran recommendation rate. Go-to-market is primarily community and VSO-driven rather than paid acquisition, and brand visibility has been materially elevated by media coverage and policy wins during 2025–2026.
VETS, Veterans Exploring Treatment Solutions firmographics
Firmographics- Name
- VETS, Veterans Exploring Treatment Solutions
- Legal name
- VETS, Inc.
- Website
- https://vetsolutions.org
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 that funds U.S. veterans' access to psychedelic-assisted therapies through grants, research partnerships with Stanford and Ohio State, and veteran-focused policy advocacy.
- Ownership category
- akta.pro rank
VETS, Veterans Exploring Treatment Solutions industry classification
Industry- Product category
- Veteran Mental Health Services
- NAICS
- Voluntary Health Organizations (813212), Other Grantmaking and Giving Services (813219)
- akta.pro primary industry
- Behavioral Health & Substance Use Program Funding (Public Health) (HLAJALAI)
Keywords
Where VETS, Veterans Exploring Treatment Solutions is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
VETS, Veterans Exploring Treatment Solutions business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Revenue model
- Individual Donations: Individual donors contribute to VETS' mission, including major donors, recurring donors, and event attendees. In 2025, individuals contributed $3.3M out of total income of $6.7M.
- Foundation Grants: Foundation funding supports research, advocacy, and program operations. In 2025, foundations contributed $1.99M.
- Corporate Partnerships: Corporate sponsors support VETS events and programs, including Black Rifle Coffee Company, Ambio Life Sciences, Dr. Bronner's, and others. In 2025, corporations contributed $681K.
- Events: The annual Torchbearer Ball and other fundraising events generate revenue. The 2025 Torchbearer Ball raised over $1.4 million.
- Merchandise Sales: VETS operates an online store selling merchandise including the Foundational Healing Workbook and branded items.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
VETS, Veterans Exploring Treatment Solutions product offering
Product offeringCore offering
VETS provides grant funding and wraparound support to help U.S. military veterans and their spouses access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted third-party international facilities, where these treatments are legal or unregulated. The organization supplements grant funding with preparation and integration coaching, meditation, yoga, and community resources. VETS also funds research (Stanford, Ohio State, UCSF) and drives policy advocacy (Texas Ibogaine Initiative, California AB 1103, federal executive orders) to expand domestic access.
Product overview
VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit organization offering a holistic ecosystem of programs supporting veterans' access to psychedelic-assisted therapies. The core offering is the Foundational Healing Grants program, which provides funding and wraparound support for veterans to access treatments including ibogaine, ketamine, psilocybin, MDMA, and 5-MeO-DMT at international facilities. This is supplemented by the free VETS E-Course for education, the VETS Community Platform for ongoing integration support, the VETS Foundational Healing Workbook for preparation, and Meditation and Breathing Exercises for wellness. The organization also produces advocacy content including the Netflix documentary 'In Waves and War' and hosts the annual Torchbearer Ball fundraising event. All services are designed to address the veteran suicide epidemic through three pillars: resources (direct support), research (scientific validation), and advocacy (policy change).
Differentiator
Problem solved
Functional benefit
Products and services
- Foundational Healing Grants Grant program that funds U.S. military veterans and their spouses to access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted international facilities, paired with preparation and integration coaching, meditation, yoga, and community resources.
- VETS Foundational Healing Workbook
Quantifiable outcome
- 93.2% of polled VETS grant recipients feel less depressed after treatment
- +4 more outcomes
Companies that use VETS, Veterans Exploring Treatment Solutions
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
VETS, Veterans Exploring Treatment Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
VETS, Veterans Exploring Treatment Solutions partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core and minor.
- Stanford Brain Stimulation LabcoreVETS collaborated with Stanford Brain Stimulation Lab led by Dr. Nolan Williams on a groundbreaking Nature Medicine study examining ibogaine therapy effects on veterans with TBI and PTSD. The study enrolled 30 U.S. Special Operations veterans, all supported by VETS through Foundational Healing Grants. Results showed dramatic improvements including reduced suicidal ideation from 47% to 7%.
- Ambio Life SciencescoreAll study participants received treatment at Ambio Life Sciences, an independent clinic in Mexico providing somatic therapies alongside psychedelic therapies in a medically supported environment. VETS provided travel funding as part of its grants program.
- Jonathan Dickinson (Ambio CEO)minorJonathan Dickinson, CEO of Ambio Life Sciences, provided statement reinforcing the safety and efficacy findings from the Stanford study and highlighting ibogaine's healing potential.
- Ohio State University Center for Psychedelic Drug Research and Education (CPDRE)coreDr. Alan Davis leads a program evaluation of VETS grant recipients - the largest longitudinal observational study of psychedelic treatment in U.S. veterans with over 130 participants enrolled. Five peer-reviewed publications are in development. The study follows Dr. Davis' 2019 retrospective study of veterans receiving ibogaine therapy.
- UCSF Translational Psychedelic Research ProgramcoreFormal collaboration with UCSF's Translational Psychedelic Research Program on wellbeing assessments tracking outcomes across physical, emotional, spiritual, and social dimensions. Over 350 grant recipients completed assessments.
- VALOR Coalition (Veteran Alliance for Leadership, Outreach, and Recovery)coreVETS is a founding member of VALOR, a national coalition with Navy SEAL Foundation, Wounded Warrior Project, and Green Beret Foundation united to advance practical veteran health policy and expand research access. Launched September 2025.
- Navy SEAL FoundationcoreNavy SEAL Foundation is a founding member of VALOR coalition and has supported VETS' advocacy efforts, including AB 1103 in California. Robin King, CEO of Navy SEAL Foundation, issued statements supporting psychedelic research reform.
- Green Beret FoundationcoreGreen Beret Foundation is a founding member of VALOR coalition alongside VETS, Navy SEAL Foundation, and Wounded Warrior Project. Charlie Iacono, President and CEO, supported AB 1103 passage.
- Wounded Warrior ProjectcoreWounded Warrior Project is a founding member of VALOR coalition working to advance mental health policy and psychedelic research access for veterans.
- Texas Ibogaine Initiative (UTHealth Houston, UT Medical Branch at Galveston, Dell Medical School)coreTexas committed $100 million (public and private) for ibogaine research led by UTHealth Houston and UT Medical Branch at Galveston with support from Dell Medical School at UT Austin. VETS played central role in securing this funding.
- Texans for Greater Mental HealthminorLogan Davidson serves as both VETS Legislative Director and Executive Director of Texans for Greater Mental Health, advancing psychedelic research policy at state level.
- Home Base (Red Sox Foundation and Massachusetts General Hospital)coreEliza Dushku serves as Behavioral Health Therapist and Program Development Specialist in Psychedelic-Assisted Psychotherapy at Home Base. Home Base is dedicated to healing the invisible wounds of war for veterans, service members, and military families.
- Actual FilmsminorProduction company for In Waves and War documentary by award-winning filmmakers Jon Shenk and Bonni Cohen.
- Participant MediaminorParticipant Media produced In Waves and War documentary, bringing veteran mental health story to global Netflix audience.
- Congressman Dan CrenshawminorTexas Congressman who worked with VETS to secure psychedelic research funding in the National Defense Authorization Act.
- Americans for IbogaineminorCo-led by former Energy Secretary Rick Perry. W. Bryan Hubbard is CEO and keynote speaker at VETS events. VETS mentioned as veterans' advocacy group alongside Americans for Ibogaine in White House executive order coverage.
Scale indicators22 records
Recent moves6 records
Expansion highlights6 records
VETS, Veterans Exploring Treatment Solutions competitors and assessment
Company assessmentDirect peers
- Navy SEAL Foundation: VALOR coalition co-founder supporting Special Operations veterans and their families; shares the elite-veteran constituency and policy advocacy focus with VETS.
- Wounded Warrior Project: The largest US veteran-focused nonprofit addressing PTSD, TBI, and mental health. Direct peer and VALOR coalition co-founding partner with overlapping mental-health mission and donor base.
- Multidisciplinary Association for Psychedelic Studies (MAPS): Leading psychedelic-research nonprofit that drove FDA review of MDMA-assisted therapy. Closest analog to VETS in the psychedelic policy/research ecosystem and a likely collaborator as the veteran-use case scales.
- Heroic Hearts Project: Nonprofit funding psychedelic therapy access for veterans and first responders. Closely overlapping program model (treatment-access grants abroad) and target population.
- Americans for Ibogaine: Advocacy organization co-led by former Energy Secretary Rick Perry pushing ibogaine research and access; explicitly partnered with VETS on the White House executive order.
- Green Beret Foundation: VALOR coalition co-founder funding Special Forces veteran health and welfare. Operates in the same donor and beneficiary ecosystem as VETS.
- Home Base (Red Sox Foundation & Massachusetts General Hospital): Clinical veteran/family mental health program with an active psychedelic-assisted therapy track where VETS board member Eliza Dushku practices. Peer on treatment delivery and research integration.
- Stop Soldier Suicide: Veteran suicide prevention nonprofit with a similar mission footprint (suicide crisis focus) and overlapping donor base, though without the psychedelic-treatment emphasis.
Broad incumbents
- Iraq and Afghanistan Veterans of America (IAVA): Large, established post-9/11 veteran advocacy organization addressing mental health, suicide, and VA policy. Broader in scope but overlapping on policy advocacy and donor base.
Emerging players
- Reason for Hope Foundation: Nonprofit funding ibogaine and psychedelic-assisted therapy access; overlaps with VETS' grant model and uses REID Foundation funding, an existing VETS partner.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
VETS, Veterans Exploring Treatment Solutions social profiles
Digital presenceVETS, Veterans Exploring Treatment Solutions compliance and trust
Trust signalCompliance4 records
VETS, Veterans Exploring Treatment Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
VETS, Veterans Exploring Treatment Solutions leadership team
Management profileNumber of profiles
Profiles7 records
VETS, Veterans Exploring Treatment Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VETS, Veterans Exploring Treatment Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VETS, Veterans Exploring Treatment Solutions
What does VETS, Veterans Exploring Treatment Solutions do?
VETS provides grant funding and wraparound support to help U.S. military veterans and their spouses access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted third-party international facilities, where these treatments are legal or unregulated. The organization supplements grant funding with preparation and integration coaching, meditation, yoga, and community resources. VETS also funds research (Stanford, Ohio State, UCSF) and drives policy advocacy (Texas Ibogaine Initiative, California AB 1103, federal executive orders) to expand domestic access.
Is VETS, Veterans Exploring Treatment Solutions a public or private company?
VETS, Veterans Exploring Treatment Solutions is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was VETS, Veterans Exploring Treatment Solutions founded?
VETS, Veterans Exploring Treatment Solutions was founded in 2019. It employs 1 to 10 people.
Where is VETS, Veterans Exploring Treatment Solutions based?
VETS, Veterans Exploring Treatment Solutions is headquartered in San Diego, United States, in the North America region.
How does VETS, Veterans Exploring Treatment Solutions make money?
Five revenue lines are on record. Individual Donations are the primary driver. The others are foundation Grants, corporate Partnerships, events and merchandise Sales.
Who are VETS, Veterans Exploring Treatment Solutions's main competitors?
Direct peers on record are Navy SEAL Foundation, Wounded Warrior Project, Multidisciplinary Association for Psychedelic Studies (MAPS), Heroic Hearts Project, Americans for Ibogaine, Green Beret Foundation, Home Base (Red Sox Foundation & Massachusetts General Hospital) and Stop Soldier Suicide. Iraq and Afghanistan Veterans of America (IAVA) is listed as a broad incumbent. Reason for Hope Foundation is listed as an emerging player.
Does VETS, Veterans Exploring Treatment Solutions have an API?
No public API is recorded for VETS, Veterans Exploring Treatment Solutions.
What industry is VETS, Veterans Exploring Treatment Solutions in?
VETS, Veterans Exploring Treatment Solutions's product category is Veteran Mental Health Services. Its primary akta.pro industry code is HLAJALAI, Behavioral Health & Substance Use Program Funding (Public Health). Its NAICS code is 813212.